Steinberg GD,Carter BS,Beaty TH,et al. Family history and the risk of prostate cancer[J]. Prostate,1990,17(4):337-347.
[4]
Eeles RA,Kote-Jarai Z,Giles GG,et al. Multiple newly identified loci associated with prostate cancer susceptibility[J]. Nat Genet,2008,40(3):316-321.
[5]
Takata R,Akamatsu S,Kubo M,et al. Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population[J]. Nat Genet,2010,42(9):751-754.
Hsing AW,Chokkalingam AP. Prostate cancer epidemiology[J]. Front Biosci,2006,11:1388-1413.
[9]
Breslow N,Chan CW,Dhom G,et al. Latent carcinoma of prostate at autopsy in seven areas. The International agency for research on cancer,lyons,france[J]. Int J Cancer,1977,20(5):680-688.
Haiman CA,Stampfer MJ,Giovannucci E,et al. The relationship between a polymorphism in CYP17 with plasma hormone levels and prostate cancer[J]. Cancer Epidemiol Biomarkers Prev,2001,10(7):743-748.
Joung J Y,Park S,Yoon H,et al. Association of common variations of 8q24 with the risk of prostate cancer in Koreans and a review of the Asian population[J]. BJU Int,2012,110(6):18-25.
[17]
Liu F,Hsing AW,Wang X,et al. Systematic confirmation study of reported prostate cancer risk-associated single nucleotide polymorphisms in Chinese men[J]. Cancer Sci,2011,102(10):1916-1920.
[18]
Zheng SL,Hsing A W,Sun J,et al. Association of 17 prostate cancer susceptibility loci with prostate cancer risk in Chinese men[J]. Prostate,2010,70(4):425-432.